Health Care & Life Sciences » Pharmaceuticals | Boryung Pharmaceutical Co. Ltd.

Boryung Pharmaceutical Co. Ltd.

Boryung Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
 KRW582.15
Market Cap
 KRW493.97 B
Shares Outstanding
 44.2 M
Public Float
 18.53 M

Profile

Address
Boryung Building
Seoul SL 03127
Korea, Republic Of
Employees -
Website http://www.boryung.co.kr
Updated 07/08/2019
Boryung Pharmaceutical Co., Ltd. engages in the manufacture of of drug products. Its main products include Kanarb, Dukarb, Tuvero, TODULA, BESTO, and gelfosM. Its products include cardiovascular, antibiotics, anticancer, amino acid, cosmetics, gastrointestinal, and API.

Financials

View All
Created with Highcharts 5.0.14Boryung Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.14 12714 12721 59121 59120 30120 3015 6145 61456 69956 69921 89721 897201320142015201620172018010k20k30k40k50k60k
Created with Highcharts 5.0.14Boryung Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.327 279327 279359 491359 491401 350401 350409 140409 140422 721422 721460 402460 4022013201420152016201720180100k200k300k400k500k

Eun-Sun Kim
Co-Chief Executive Officer & Director
Tae-Hong Choi
Co-Chief Executive Officer & Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.